ArriVent BioPharma, Inc. (AVBP) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Join SI Premium – FREE
ArriVent BioPharma, Inc. (NASDAQ: AVBP) reported Q3 EPS of ($0.61), $0.07 worse than the analyst estimate of ($0.54).
For earnings history and earnings-related data on ArriVent BioPharma, Inc. (AVBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- UBS Downgrades Klarna (KLAR) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
